References
- Asthma prevalence, health care use, and mortality: United States, 2005–2009. National Health Statistics Reports: January 12, 2011.
- Barnes P. Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 1998; 158:S123–S132.
- Advenier C, Sarria B, Naline E, Puybasset F, Lagente A. Contractile activity of three endothelins (ET-l, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol 1990; 100:168–172.
- Goldie R, Henry P, Knoti P, Seif G, Luttmann M, Hay D. Endothelin-l receptor density, distribution, and function in human isolated asthmatic airways. Am J Respir Crit Care Med 1995; 152:1653–1658.
- Chalmers G, Little S, Patel K, Thomas N. Endothelin-1-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1997; 156:382–388.
- Gamal Y, Hossney E, Awwad K, Mabroouk R, Boseila N. Plasma endothelin-1 immunoreactivity in asthmatic children. Ann Allergy Asthma Immunol 2002; 88:370–373.
- Trakada G, Tsourapis S, Marangos M, Spiropoulos K. Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir Med 2000; 94:992–996.
- Goldie R, Henry P. Minireview: Endothelins and asthma. Life Sci 1999; 65:1–1.
- Hay D, Hubbard W, Undem B. Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. Br J Pharmacol 1993; 110:955–962.
- Marini M, Carpi S, Bellini A, Patalano F, Mattoli S. Endothelin-1 induces increased fibronectin expression in human bronchial epithelial cells. Biochem Biophys Res Commun 2000; 220:896–899.
- Foley R, Metersky M. Successful treatment of sarcoid-associated pulmonary hypertension with bosentan. Respiration 2008; 75:221–224.
- National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Summary report 2007. http://www.nhlbi.nih.gov/quidelines/asthma/asthgdln.htm
- Israel E, Rubin P, Kemp J, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993; 119:1059–1066.
- Redington A, Springhall D, Qing-Hai M, Tuck A, Holgate S, Polak J, Howarth P. Immunoreactive endothelin in bronchial biopsy specimens: Increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol 1997; 100:544–552.
- Zietkowski Z, Skiepko R, Tomasiak M, Bodzenta-Lukaszyk A. Endothelin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Med 2008; 102:470–474.
- Landgraf R, Jancar S. Endothelin A receptor antagonist modulates lymphocyte and eosinophil infiltration, hyperreactivity and mucous in murine asthma. Int Immunopharmacol 2008; 8:1748–1753.
- Finnsnes F, Lyberg T, Christensen G, Skjonsbrg A. Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation. Am J Physiol Lung Cell Mol Physiol 2001; 280:L659–L665.
- Tracleer [Package Insert]. South San Francisco, CA: Actelion Pharmaceuticals US, 2012.